Early Ileocecal Resection for Crohn’s Disease

Danilov M.A.; Demidova A.A.; Leontev A.V.; Tsvirkun V.V.

doi:https://doi.org/10.17116/dokgastro20231203110

Close metadata

OBJECTIVE

This single-center retrospective study’s objective is to evaluate the results of early ileocecal resection (ICR) in patients with localized Crohn’s disease compared to later surgery performed following protracted anti-inflammatory and immunosuppressive medication therapy.

MATERIAL AND METHODS

85 patients with stricturing Crohn’s disease were subjected to a multivariate retrospective analysis. In 30 of them, ileocecal resection was done right away after the diagnosis without any prior medication (early ICR), whereas in 55 of them, surgery was done after receiving medical therapy. Patients in both groups were similar in terms of gender, age, and BMI. The need for medication after the operation, as well as the types and frequency of postoperative complications, were evaluated. A follow-up endoscopy was performed 3 and 6 months after the operation.

RESULTS

The number and frequency of postoperative complications did not vary between the groups. Both groups had a comparable rate of temporary stoma formation (13.3% vs. 10.9%, p=0.08). Differences were found in the number of patients requiring medical treatment (26.6% vs. 78.1%, p<0.001), time to start medical therapy following surgery (15 months vs. 2 months, p<0.001), and the frequency of therapy escalation (3.3% vs. 38.1%, p<0.001).

CONCLUSION

Early ileocecal resection decreases the requirement for medical therapy in a considerable number of cases and prolongs the time before Crohn’s disease relapses.

Keywords:

Crohn’s disease

Ileocecal resection

Inflammatory bowel disease

Surgery

Authors:

Danilov M.A.

A.S. Loginov Moscow Clinical Scientific Center Department of Health of Moscow

ORCID: 0000-0001-9439-9873

Demidova A.A.

A.S. Loginov Moscow Clinical Scientific Center Department of Health of Moscow

ORCID: 0000-0001-5141-1692

Leontev A.V.

A.S. Loginov Moscow Clinical Scientific Center Department of Health of Moscow

ORCID: 0000-0003-3363-6841

Tsvirkun V.V.

A.S. Loginov Moscow Clinical Scientific Center Department of Health of Moscow

ORCID: 0000-0001-5169-2199

Received:

04.04.2023

Accepted:

20.06.2023

Close metadata

References:

Kniazev OV, Shkurko TV, Kagramanova AV, Veselov AV, Nikonov EL. Epidemiology of inflammatory bowel disease. State of the problem (review). Russian Journal of Evidence-Based Gastroenterology. 2020;9(2):66-73. (In Russ.) https://doi.org/10.17116/dokgastro2020902166
Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, Sung JJY, Kaplan GG. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. The Lancet. 2017;390(10114):2769-2778. https://doi.org/10.1016/S0140-6736(17)32448-0
Kappelman MD, Rifas-Shiman SL, Porter CQ, Ollendorf DA, Sandler RS, Galanko JA, Finkelstein JA. Direct health care costs of Crohn’s disease and ulcerative colitis in US children and adults. Gastroenterology. 2008;135(6):1907-1913. https://doi.org/10.1053/j.gastro.2008.09.012
Voskuil MD, Bangma A, Weersma RK, Festen EAM. Predicting (side) effects for patients with inflammatory bowel disease: The promise of pharmacogenetics. World Journal of Gastroenterology. 2019;25(21):2539-2548. https://doi.org/10.3748/wjg.v25.i21.2539
De Souza HSP, Fiocchi C, Iliopoulos D. The IBD interactome: an integrated view of aetiology, pathogenesis and therapy. Nature Reviews Gastroenterology and Hepatology. 2017;14(12):739-749. https://doi.org/10.1038/nrgastro.2017.110
Brazil JC, Parkos CA. Pathobiology of neutrophil-epithelial interactions. Immunological Reviews. 2016;273(1):94-111. https://doi.org/10.1111/imr.12446
Li N, Shi RH. Updated review on immune factors in pathogenesis of Crohn’s disease. World Journal of Gastroenterology. 2018; 24(1):15. https://doi.org/10.3748/wjg.v24.i1.15
Pillai N, Dusheiko M, Maillard MH, Rogler G, Brüngger B, Bähler C, Pittet VEH; Swiss IBD Cohort Study Group. The evolution of health care utilisation and costs for inflammatory bowel disease over ten years. Journal of Crohn’s and Colitis. 2019;13(6):744-754. https://doi.org/10.1093/ecco-jcc/jjz003
Hisamatsu T, Matsumoto T, Watanabe K, Nakase H, Motoya S, Yoshimura N, Ishida T, Kato S, Nakagawa T, Esaki M, Nagahori M, Matsui T, Naito Y, Kanai T, Suzuki Y, Nojima M, Watanabe M, Hibi T; DIAMOND study group. Concerns and side effects of azathioprine during adalimumab induction and maintenance therapy for Japanese patients with Crohn’s Disease: a subanalysis of a prospective randomised clinical trial [DIAMOND Study]. Journal of Crohn’s and Colitis. 2019;13(9):1097-1104. https://doi.org/10.1093/ecco-jcc/jjz030
Burisch J, Kiudelis G, Kupcinskas L, Kievit HAL, Andersen KW, Andersen V, Salupere R, Pedersen N, Kjeldsen J, D’Incà R, Valpiani D, Schwartz D, Odes S, Olsen J, Nielsen KR, Vegh Z, Lakatos PL, Toca A, Turcan S, Katsanos KH, Christodoulou DK, Fumery M, Gower-Rousseau C, Zammit SC, Ellul P, Eriksson C, Halfvarson J, Magro FJ, Duricova D, Bortlik M, Fernandez A, Hernández V, Myers S, Sebastian S, Oksanen P, Collin P, Goldis A, Misra R, Arebi N, Kaimakliotis IP, Nikuina I, Belousova E, Brinar M, Cukovic-Cavka S, Langholz E, Munkholm P; Epi-IBD group. Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study. Gut. 2019;68(3):423-433. https://doi.org/10.1136/gutjnl-2017-315568
Dittrich AE, Sutton RT, Haynes K, Wang H, Fedorak RN, Kroeker KI. Incidence rates for surgery in Crohn’s disease have decreased: a population-based time-trend analysis. Inflammatory Bowel Diseases. 2020;26(12):1909-1916. https://doi.org/10.1093/ibd/izz315
Wong DJ, Roth EM, Feuerstein JD, Poylin VY. Surgery in the age of biologics. Gastroenterology Report. 2019;7(2):77-90. https://doi.org/10.1093/gastro/goz004
Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG clinical guideline: management of Crohn’s disease in adults. The American Journal of Gastroenterology. 2018; 113(4):481-517. https://doi.org/10.1038/ajg.2018.27
Ivashkin VT, Shelygin YA, Khalif IL, Belousova EA, Shifrin OS, Abdulganieva DI, Abdulhakov RA, Alekseeva OP, Alekseenko SA, Achkasov SI, Baranovsky AYu, Bolikhov KV, Valuyskikh EYu, Vardanyan AV, Veselov AV, Veselov VV, Golovenko AO, Golovenko OV, Grigoryev EG, Gubonina IV, Zhigalova TN, Kashnikov VN, Kizova EA, Knyazev OV, Kostenko NV, Kulyapin AV, Morozova NA, Muravyev AV, Nizov AA, Nikitina NV, Nikolaeva NN, Nikulina NV, Odintsova AKh, Osipenko MF, Pavlenko VV, Parfenov AI, Poluektova EA, Potapov AS, Rumyantsev VG, Svetlova IO, Sitkin SI, Timerbulatov VM, Tkachev AV, Tkachenko EI, Frolov SA, Khubezov DA, Chashkova EYu, Shapina MV, Shchukina OB, Yakovlev AA. Clinical guide of Russian association of gastroenterology and Russian association of coloproctology on diagnostics and treatment of Crohn’s disease. Koloproktologia. 2017;(2):7-29. (In Russ.). https://doi.org/10.33878/2073-7556-2017-0-2-7-29
Latella G, Cocco A, Angelucci E, Viscido A, Bacci S, Necozione S, Caprilli R. Clinical course of Crohn’s disease first diagnosed at surgery for acute abdomen. Digestive and Liver Disease. 2009;41(4):269-276. https://doi.org/10.1016/j.dld.2008.09.010
Toh JWT, Wang N, Young CJ, Rickard MJFX, Keshava A, Stewart P, Kariyawasam V, Leong R; and the Sydney IBD Cohort Collaborators. Major abdominal and perianal surgery in Crohn’s disease: long-term follow-up of Australian patients with Crohn’s disease. Diseases of the Colon and Rectum. 2018;61(1);67-76. https://doi.org/10.1097/DCR.0000000000000975
Golovics PA, Lakatos L, Nagy A, Pandur T, Szita I, Balogh M, Molnar C, Komaromi E, Lovasz BD, Mandel M, Veres G, Kiss LS, Vegh Z, Lakatos PL. Is early limited surgery associated with a more benign disease course in Crohn’s disease? World Journal of Gastroenterology. 2013;19(43):7701-7710. https://doi.org/10.3748/wjg.v19.i43.7701
Martins R, Carmona C, George B, Epstein J; Guideline Committee. Management of Crohn’s disease: summary of updated NICE guidance. BMJ. 2019;367:l5940. https://doi.org/10.1136/bmj.l5940
Preiß JC, Bokemeyer B, Buhr HJ, Dignaß A, Häuser W, Hartmann F, Herrlinger KR, Kaltz B, Kienle P, Kruis W, Kucharzik T, Langhorst J, Schreiber S, Siegmund B, Stallmach A, Stange EF, Stein J, Hoffmann JC; German Society of Gastroenterology. [Updated German clinical practice guideline on” Diagnosis and treatment of Crohn’s disease” 2014]. Zeitschrift fur Gastroenterologie. 2014;52(12):1431-1484. https://doi.org/10.1055/s-0034-1385199
Peyrin-Biroulet L, Bouhnik Y, Roblin X, Bonnaud G, Hagège H, Hébuterne X; gastroenterologist nominal group. French national consensus clinical guidelines for the management of Crohn’s disease. Digestive and Liver Disease. 2017;49(4):368-377. https://doi.org/10.1016/j.dld.2016.12.008
Flemming S, Kim M, Germer CT. Terminal ileitis in Crohn’s disease — Is primary surgery the better treatment? Der Chirurg. 2021;92:16-20. https://doi.org/10.1007/s00104-020-01294-5
Shimada N, Ohge H, Kono T, Sugitani A, Yano R, Watadani Y, Uemura K, Murakami Y, Sueda T. Surgical recurrence at anastomotic site after bowel resection in Crohn’s disease: comparison of Kono-S and end-to-end anastomosis. Journal of Gastrointestinal Surgery. 2019;23(2):312-319. https://doi.org/10.1007/s11605-018-4012-6
Lowney JK, Dietz DW, Birnbaum EH, Kodner IJ, Mutch MG, Fleshman JW. Is there any difference in recurrence rates in laparoscopic ileocolic resection for Crohn’s disease compared with conventional surgery? A long-term, follow-up study. Diseases of the Colon and Rectum. 2006;49(1);58-63. https://doi.org/10.1007/s10350-005-0214-6
Coffey CJ, Kiernan MG, Sahebally SM, Jarrar A, Burke JP, Kiely PA, Shen B, Waldron D, Peirce C, Moloney M, Skelly M, Tibbitts P, Hidayat H, Faul PN, Healy V, O’Leary PD, Walsh LG, Dockery P, O’Connell RP, Martin ST, Shanahan F, Fiocchi C, Dunne CP. Inclusion of the mesentery in ileocolic resection for Crohn’s disease is associated with reduced surgical recurrence. Journal of Crohn’s and Colitis. 2018;12(10);1139-1150. https://doi.org/10.1093/ecco-jcc/jjx187
de Groof EJ, Stevens TW, Eshuis EJ, Gardenbroek TJ, Bosmans JE, van Dongen JM, Mol B, Buskens CJ, Stokkers PCF, Hart A, D’Haens GR, Bemelman WA, Ponsioen CY. Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn’s disease: the LIR! C Trial. Gut. 2019;68(10);1774-1780. https://doi.org/10.1136/gutjnl-2018-317539
Toh JW, Stewart P, Rickard MJ, Leong R, Wang N, Young CJ. Indications and surgical options for small bowel, large bowel and perianal Crohn’s disease. World Journal of Gastroenterology. 2016;22(40):8892-8904. https://doi.org/10.3748/wjg.v22.i40.8892
Tan JJ, Tjandra JJ. Laparoscopic surgery for Crohn’s disease: a meta-analysis. Diseases of the Colon and Rectum. 2007;50(5);576-585. https://doi.org/10.1007/s10350-006-0855-0
Eshuis EJ, Slors JF, Stokkers PC, Sprangers MA, Ubbink DT, Cuesta MA, Pierik EG, Bemelman WA. Long-term outcomes following laparoscopically assisted versus open ileocolic resection for Crohn’s disease. Journal of British Surgery. 2010;97(4):563-568. https://doi.org/10.1002/bjs.6918
Ponsioen CY, de Groof EJ, Eshuis EJ, Gardenbroek TJ, Bossuyt PMM, Hart A, Warusavitarne J, Buskens CJ, van Bodegraven AA, Brink MA, Consten ECJ, van Wagensveld BA, Rijk MCM, Crolla RMPH, Noomen CG, Houdijk APJ, Mallant RC, Boom M, Marsman WA, Stockmann HB, Mol B, de Groof AJ, Stokkers PC, D’Haens GR, Bemelman WA. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn’s disease: a randomised controlled, open-label, multicentre trial. The Lancet. Gastroenterology and Hepatology. 2017;2(11):785-792. https://doi.org/10.1016/S2468-1253(17)30248-0
Aratari A, Papi C, Leandro G, Viscido A, Capurso L, Caprilli R. Early versus late surgery for ileo‐caecal Crohn’s disease. Alimentary Pharmacology and Therapeutics. 2007;26(10):1303-1312. https://doi.org/10.1111/j.1365-2036.2007.03515.x
Lee JM, Lee KM, Kim JS, Kim YS, Cheon JH, Ye BD, Kim YH, Han DS, Lee CK, Park HJ. Postoperative course of Crohn disease according to timing of bowel resection: results from the CONNECT Study. Medicine. 2018;97(16):e0459. https://doi.org/10.1097/MD.0000000000010459
An V, Cohen L, Lawrence M, Thomas M, Andrews J, Moore J. Early surgery in Crohn’s disease a benefit in selected cases. World Journal of Gastrointestinal Surgery. 2016;8(7):492-500. https://doi.org/10.4240/wjgs.v8.i7.492
Riss S, Schuster I, Papay P, Herbst F, Mittlböck M, Chitsabesan P, Stift A. Surgical recurrence after primary ileocolic resection for Crohn’s disease. Techniques in Coloproctology. 2014;18(4):365-371. https://doi.org/10.1007/s10151-013-1061-4
Patel SV, Patel SV, Ramagopalan SV, Ott MC. Laparoscopic surgery for Crohn’s disease: a meta-analysis of perioperative complications and long term outcomes compared with open surgery. BMC Surgery. 2013;13(1):1-13. https://doi.org/10.1186/1471-2482-13-14
Dasari BVM, McKay D, Gardiner K. Laparoscopic versus open surgery for small bowel Crohn’s disease. Cochrane Database of Systematic Reviews. 2011;(1):CD006956. https://doi.org/10.1002/14651858.CD006956.pub2
Eshuis EJ, Polle SW, Slors JF, Hommes DW, Sprangers MA, Gouma DJ, Bemelman WA. Long-term surgical recurrence, morbidity, quality of life, and body image of laparoscopic-assisted vs. open ileocolic resection for Crohn’s disease: a comparative study. Diseases of the Colon and Rectum. 2008;51(6):858-867. https://doi.org/10.1007/s10350-008-9195-6
Knowles SR, Graff LA, Wilding H, Hewitt C, Keefer L, Mikocka-Walus A. Quality of life in inflammatory bowel disease: a systematic review and meta-analyses—part I. Inflammatory Bowel Diseases. 2018;24(4):742-751. https://doi.org/10.1093/ibd/izx100
Adamina M, Bonovas S, Raine T, Spinelli A, Warusavitarne J, Armuzzi A, Bachmann O, Bager P, Biancone L, Bokemeyer B, Bossuyt P, Burisch J, Collins P, Doherty G, El-Hussuna A, Ellul P, Fiorino G, Frei-Lanter C, Furfaro F, Gingert C, Gionchetti P, Gisbert JP, Gomollon F, González Lorenzo M, Gordon H, Hlavaty T, Juillerat P, Katsanos K, Kopylov U, Krustins E, Kucharzik T, Lytras T, Maaser C, Magro F, Marshall JK, Myrelid P, Pellino G, Rosa I, Sabino J, Savarino E, Stassen L, Torres J, Uzzan M, Vavricka S, Verstockt B, Zmora O. ECCO guidelines on therapeutics in Crohn’s disease: surgical treatment. Journal of Crohn’s and Colitis. 2020;14(2):155-168. https://doi.org/10.1093/ecco-jcc/jjz187